Siller, A.; Seekircher, L.; Astl, M.; Tschiderer, L.; Wachter, G.A.; Penz, J.; Pfeifer, B.; Huber, A.; Gaber, M.; Schennach, H.;
et al. Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023. Vaccines 2024, 12, 284.
https://doi.org/10.3390/vaccines12030284
AMA Style
Siller A, Seekircher L, Astl M, Tschiderer L, Wachter GA, Penz J, Pfeifer B, Huber A, Gaber M, Schennach H,
et al. Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023. Vaccines. 2024; 12(3):284.
https://doi.org/10.3390/vaccines12030284
Chicago/Turabian Style
Siller, Anita, Lisa Seekircher, Manfred Astl, Lena Tschiderer, Gregor A. Wachter, Julia Penz, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach,
and et al. 2024. "Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023" Vaccines 12, no. 3: 284.
https://doi.org/10.3390/vaccines12030284
APA Style
Siller, A., Seekircher, L., Astl, M., Tschiderer, L., Wachter, G. A., Penz, J., Pfeifer, B., Huber, A., Gaber, M., Schennach, H., & Willeit, P.
(2024). Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023. Vaccines, 12(3), 284.
https://doi.org/10.3390/vaccines12030284
